May 1 |
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
|
Apr 24 |
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
|
Apr 8 |
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease
|
Apr 8 |
Supernus stock slides as FDA rejects Parkinson's disease infusion device
|
Apr 8 |
Supernus Provides Regulatory Update for SPN-830
|
Mar 6 |
Supernus to Participate in Two Upcoming Investor Conferences
|
Mar 5 |
11 Best Small Cap Pharma Stocks to Invest In
|
Mar 4 |
Supernus Pharmaceuticals: Moving Through An 'Inflection Year'
|
Feb 29 |
Supernus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
|
Feb 28 |
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
|